Nanollose Limited (ASX:NC6) (FRA:N0L) is pleased to advise that it has entered into a collaboration agreement with innovative vegan leather and materials company, von Holzhausen Inc.
Nanollose Limited (ASX:NC6) (FRA:N0L) a leading bio-materials company, focused on commercialising scalable technology to create fibres and fabrics with minimal environmental impact, is pleased to provide shareholders with an overview of its activities for the period ended 31 March 2022.
For most pet owners, there is no price too dear for their animal healthcare but with an opportunity to reduce annual expenses most have quickly signed up to the Best Mates program run by Apiam Animal Health Limited (ASX:AHX).
Nanollose Limited (ASX:NC6) (FRA:N0L) is pleased to advise that it has entered into a collaboration agreement with Orta Anadolu Ticaret Ve Sanayi Isletmesi T.A.S, a global leader in the development, manufacture and supply of sustainable denim.
Despite having only received a $700k government grant to build a much needed viral vaccine facility, Apiam Animal Health Limited (ASX:AHX) is already eyeing production within the next 12 months, potentially including one for Japanese Encephalitis which is currently impacting the Australian's pig industry.
VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has today executed a binding agreement for the sale of its wholly owned subsidiary Invictus BioPharma Pty Ltd.
VGI Health Technology Limited (NSX:VTL) is pleased to announce that the United States Patent and Trademarks Office (USPTO) intends to grant a divisional patent for the 'Transmucosal Delivery of Tocotrienols' to its wholly-owned subsidiary Invictus Biotechnology Pty Ltd.
